abstract |
Histone deacetylase inhibitors (HDAC inhibitors) and compositions containing them are disclosed. Also disclosed are methods of treating diseases and conditions where HDAC inhibition is effective, such as cancer, neurodegenerative diseases, neurological diseases, traumatic brain injury, stroke, malaria, autoimmune diseases, autism, and inflammation . |